|
Diabetes, Vol 40, Issue 5 648-651, Copyright © 1991 by American Diabetes Association
Exclusive expression of MHC class II proteins on CD45+ cells in pancreatic islets of NOD mice
MF McInerney, S Rath and CA Janeway
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510.
The expression of MHC class II molecules on beta-cells of the pancreatic
islet has been proposed to play a role in the genesis of insulin-dependent
diabetes mellitus in the NOD mouse. We investigated this by
immunofluorescent double labeling of islet cells with anti-MHC and
anti-CD45 to identify cells of hematopoietic origin. MHC class I expression
increased with age on CD45- islet cells. MHC class II expression was not
observed on CD45- islet cells at any age; the only cells in the islet that
were MHC class II positive were also CD45+. This indicates that all MHC
class II-positive cells in the islet are lymphoid cells that infiltrate the
islet, whereas the islet endocrine cells express no MHC class II molecules.
However, an increase in MHC class I expression occurred on beta-cells, and
this may play a role in immunopathogenesis.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. B. J. Wong, R. Bos, and L. A. Sherman
Tumor-Specific CD4+ T Cells Render the Tumor Environment Permissive for Infiltration by Low-Avidity CD8+ T Cells
J. Immunol.,
March 1, 2008;
180(5):
3122 - 3131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Saxena, J. K. Ondr, A. F. Magnusen, D. H. Munn, and J. D. Katz
The Countervailing Actions of Myeloid and Plasmacytoid Dendritic Cells Control Autoimmune Diabetes in the Nonobese Diabetic Mouse
J. Immunol.,
October 15, 2007;
179(8):
5041 - 5053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Lewis, L. Shapiro, O. J. Bowers, and C. A. Dinarello
{alpha}1-Antitrypsin monotherapy prolongs islet allograft survival in mice
PNAS,
August 23, 2005;
102(34):
12153 - 12158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Smith, T. Patterson, and M. E. Pauza
Transgenic Ly-49A Inhibits Antigen-Driven T Cell Activation and Delays Diabetes
J. Immunol.,
April 1, 2005;
174(7):
3897 - 3905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Pierce, A. Svetlanov, M. S. Horwitz, and D. V. Serreze
Adenovirus Early Region 3 Transgenes Expressed in {beta} Cells Prevent Autoimmune Diabetes in Nonobese Diabetic Mice: Effects of Deleting the Adenovirus Death Protein 11.6K
J. Virol.,
January 1, 2005;
79(1):
619 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Havari, A. M. Lennon-Dumenil, L. Klein, D. Neely, J. A. Taylor, M. F. McInerney, K. W. Wucherpfennig, and M. A. Lipes
Expression of the B7.1 Costimulatory Molecule on Pancreatic {beta} Cells Abrogates the Requirement for CD4 T Cells in the Development of Type 1 Diabetes
J. Immunol.,
July 15, 2004;
173(2):
787 - 796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yamanouchi, J. Verdaguer, B. Han, A. Amrani, P. Serra, and P. Santamaria
Cross-Priming of Diabetogenic T Cells Dissociated from CTL-Induced Shedding of {beta} Cell Autoantigens
J. Immunol.,
December 15, 2003;
171(12):
6900 - 6909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gurlo and H. v. Grafenstein
Antigen-independent cross-talk between macrophages and CD8+ T cells facilitates their cooperation during target destruction
Int. Immunol.,
September 1, 2003;
15(9):
1063 - 1071.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Darwiche, M. M. W. Chong, P. Santamaria, H. E. Thomas, and T. W. H. Kay
Fas Is Detectable on {beta} Cells in Accelerated, But Not Spontaneous, Diabetes in Nonobese Diabetic Mice
J. Immunol.,
June 15, 2003;
170(12):
6292 - 6297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Hamilton-Williams, S. E. Palmer, B. Charlton, and R. M. Slattery
Beta cell MHC class I is a late requirement for diabetes
PNAS,
May 27, 2003;
100(11):
6688 - 6693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Pierce, H. D. Chapman, C. M. Post, A. Svetlanov, S. Efrat, M. Horwitz, and D. V. Serreze
Adenovirus Early Region 3 Antiapoptotic 10.4K, 14.5K, and 14.7K Genes Decrease the Incidence of Autoimmune Diabetes in NOD Mice
Diabetes,
May 1, 2003;
52(5):
1119 - 1127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Quinn, M. F. McInerney, and E. E. Sercarz
MHC Class I-Restricted Determinants on the Glutamic Acid Decarboxylase 65 Molecule Induce Spontaneous CTL Activity
J. Immunol.,
August 1, 2001;
167(3):
1748 - 1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wen, F. S. Wong, J. Tang, N.-Y. Chen, M. Altieri, C. David, R. Flavell, and R. Sherwin
In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (HLA)-DQ Molecules to the Development of Diabetes
J. Exp. Med.,
January 3, 2000;
191(1):
97 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Anderson, B.-J. Park, J. Verdaguer, A. Amrani, and P. Santamaria
Prevalent CD8+ T cell response against one peptide/MHC complex in autoimmune diabetes
PNAS,
August 3, 1999;
96(16):
9311 - 9316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Kurrer, S. V. Pakala, H. L. Hanson, and J. D. Katz
beta cell apoptosis in T cell-mediated autoimmune diabetes
PNAS,
January 7, 1997;
94(1):
213 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1991 by the American Diabetes Association.
|
|
| |
|